71 related articles for article (PubMed ID: 7229823)
1. Spectral model of leishmaniasis in congenic strains of mice.
Semprevivo LH; DeTolla LJ; Passmore HC; Palczuk NC
J Parasitol; 1981 Feb; 67(1):8-14. PubMed ID: 7229823
[TBL] [Abstract][Full Text] [Related]
2. Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.
Rezai HR; Farrell J; Soulsby EL
Clin Exp Immunol; 1980 Jun; 40(3):508-14. PubMed ID: 6968259
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.
Bradley DJ; Kirkley J
Clin Exp Immunol; 1977 Oct; 30(1):119-29. PubMed ID: 606433
[TBL] [Abstract][Full Text] [Related]
4. Correlation of hyperplasia, splenomegaly and hepatomegaly with parasite population in BIO.LP-a mice infected with Leishmania donovani.
Premvati G
J Trop Med Hyg; 1979 May; 82(5):105-8. PubMed ID: 490751
[TBL] [Abstract][Full Text] [Related]
5. Genetic control of acquired resistance to visceral leishmaniasis in mice.
DeTolla LJ; Semprevivo LH; Palczuk NC; Passmore HC
Immunogenetics; 1980; 10(4):353-61. PubMed ID: 22457927
[TBL] [Abstract][Full Text] [Related]
6. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
[TBL] [Abstract][Full Text] [Related]
7. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci.
Leclercq V; Lebastard M; Belkaid Y; Louis J; Milon G
J Immunol; 1996 Nov; 157(10):4537-45. PubMed ID: 8906832
[TBL] [Abstract][Full Text] [Related]
8. An H-11-linked gene has a parallel effect on Leishmania major and L. donovani infections in mice.
Blackwell JM; Hale C; Roberts MB; Ulczak OM; Liew FY; Howard JG
Immunogenetics; 1985; 21(4):385-95. PubMed ID: 3997209
[TBL] [Abstract][Full Text] [Related]
9. Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani.
Barbi J; Oghumu S; Rosas LE; Carlson T; Lu B; Gerard C; Lezama-Davila CM; Satoskar AR
J Infect Dis; 2007 Jun; 195(11):1713-7. PubMed ID: 17471442
[TBL] [Abstract][Full Text] [Related]
10. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
11. Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis.
Engwerda CR; Ato M; Kaye PM
Trends Parasitol; 2004 Nov; 20(11):524-30. PubMed ID: 15471704
[TBL] [Abstract][Full Text] [Related]
12. Destruction of follicular dendritic cells during chronic visceral leishmaniasis.
Smelt SC; Engwerda CR; McCrossen M; Kaye PM
J Immunol; 1997 Apr; 158(8):3813-21. PubMed ID: 9103448
[TBL] [Abstract][Full Text] [Related]
13. Comparative susceptibility of African green monkeys (Cercopithecus aethiops) to experimental infection with Leishmania leishmania donovani and Leishmania leishmania infantum.
Binhazim AA; Shin SS; Chapman WL; Olobo J
Lab Anim Sci; 1993 Feb; 43(1):37-47. PubMed ID: 8459677
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.
Melby PC; Tabares A; Restrepo BI; Cardona AE; McGuff HS; Teale JM
Exp Parasitol; 2001 Sep; 99(1):17-25. PubMed ID: 11708830
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection.
Bradley DJ
Clin Exp Immunol; 1977 Oct; 30(1):130-40. PubMed ID: 606434
[TBL] [Abstract][Full Text] [Related]
16. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
Everlien H; Hockertz S
Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
[TBL] [Abstract][Full Text] [Related]
17. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.
Sato N; Kuziel WA; Melby PC; Reddick RL; Kostecki V; Zhao W; Maeda N; Ahuja SK; Ahuja SS
J Immunol; 1999 Nov; 163(10):5519-25. PubMed ID: 10553079
[TBL] [Abstract][Full Text] [Related]
18. Targeting of parasite-specific immunoliposome-encapsulated doxorubicin in the treatment of experimental visceral leishmaniasis.
Mukherjee S; Das L; Kole L; Karmakar S; Datta N; Das PK
J Infect Dis; 2004 Mar; 189(6):1024-34. PubMed ID: 14999606
[TBL] [Abstract][Full Text] [Related]
19. The role of mannose receptor during experimental leishmaniasis.
Akilov OE; Kasuboski RE; Carter CR; McDowell MA
J Leukoc Biol; 2007 May; 81(5):1188-96. PubMed ID: 17261547
[TBL] [Abstract][Full Text] [Related]
20. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
